Research and Markets: Global Head and Neck Cancer Diagnostics Market 2015-2019 - Analysts forecast the Global Head and Neck Cancer Diagnostics Market to Grow at a CAGR of 12.86% Over the Period 2014-2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/pmlrg5/global_head_and) has announced the addition of the "Global Head and Neck Cancer Diagnostics Market 2015-2019" report to their offering.

Covered in this report

In this report, the author describes the present scenario and growth prospects of the global head and neck cancer diagnostics market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various equipment used for the following diagnostic methods:

  • Diagnostic imaging
  • Endoscopy
  • Biopsy
  • Dental diagnostics

The year 2014 witnessed the dominance of the Americas in the head and neck cancer diagnostics market, which accounted for a share of more than 47% in the overall market share.

According to the report, one of the main factors that contributed to the growth of the market was the rise in the aging population that increased the prevalence of chronic diseases, especially head and neck related cancers.

Further, the report states that the market has evolved remarkably in developed countries and has enormous prospects in emerging countries such as China, India, Indonesia, and Thailand.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors

Key vendors

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Varian Medical Systems

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Head and neck cancer: An overview

PART 06: Reimbursement and coverage: An overview

PART 07: Market landscape

PART 08: Market segmentation by method

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

For more information visit http://www.researchandmarkets.com/research/pmlrg5/global_head_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, Oncology